OYST
Income statement / Annual
Last year (2021), Oyster Point Pharma, Inc.'s total revenue was $24.54 M,
and the percentage change from the previous year is not available.
In 2021, Oyster Point Pharma, Inc.'s net income was -$104.39 M.
See Oyster Point Pharma, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$24.54 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$1.53 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$23.01 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0.94 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$24.23 M
|
$39.81 M
|
$33.63 M
|
$13.76 M
|
$3.63 M
|
| General & Administrative
Expenses |
$40.81 M
|
$31.18 M
|
$13.67 M
|
$2.98 M
|
$2.05 M
|
| Selling & Marketing
Expenses |
$54.62 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$95.44 M
|
$31.18 M
|
$13.67 M
|
$2.98 M
|
$2.05 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$119.67 M |
$70.99 M |
$47.30 M |
$16.74 M |
$5.68 M |
| Cost And Expenses |
$121.19 M |
$70.99 M |
$47.30 M |
$16.74 M |
$5.68 M |
| Interest Income |
$0.00 |
$0.00 |
$1.59 M |
$233,000.00 |
$44,000.00 |
| Interest Expense |
$3.73 M |
$0.00 |
$0.00 |
$0.00 |
$488,000.00 |
| Depreciation &
Amortization |
$141,000.00
|
$461,000.00
|
$19,000.00
|
$233,000.00
|
-$430,000.00
|
| EBITDA |
-$96.78 M
|
-$70.06 M
|
-$45.69 M
|
-$16.50 M
|
-$6.11 M
|
| EBITDA Ratio |
-3.94 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-3.95
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$3.73 M
|
$469,000.00
|
$1.59 M
|
$233,000.00
|
-$918,000.00
|
| Income Before Tax |
-$100.66 M |
-$70.52 M |
-$45.71 M |
-$16.50 M |
-$6.60 M |
| Income Before Tax Ratio
|
-4.1
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$3.73 M |
$469,000.00 |
$1.59 M |
$0.00 |
$0.00 |
| Net Income |
-$104.39 M |
-$70.52 M |
-$45.71 M |
-$16.50 M |
-$6.60 M |
| Net Income Ratio |
-4.25 |
0 |
0 |
0 |
0 |
| EPS |
-4.01 |
-2.92 |
-9.97 |
-1.83 |
-0.73 |
| EPS Diluted |
-4.01 |
-2.92 |
-9.97 |
-1.83 |
-0.73 |
| Weighted Average Shares
Out |
$26.04 M
|
$24.13 M
|
$4.59 M
|
$9.02 M
|
$9.02 M
|
| Weighted Average Shares
Out Diluted |
$26.04 M
|
$24.13 M
|
$4.59 M
|
$9.02 M
|
$9.02 M
|
| Link |
|
|
|
|
|
